Helen Elizabeth Hanby
Direktor/Vorstandsmitglied bei NIGHTSTAR THERAPEUTICS PLC
Ursprung des Netzwerks ersten Grades von Helen Elizabeth Hanby
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom.
2
| Subsidiary | Medical/Nursing Services | 2 |
Tungsten Bidco Ltd.
Tungsten Bidco Ltd. Financial ConglomeratesFinance Founded in 2019, Tungsten Bidco Ltd. is a British company that functions as an investment holding company. Part of Biogen, Inc., the company is based in Maidenhead, UK.
1
| Subsidiary | Financial Conglomerates | 1 |
Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Helen Elizabeth Hanby
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Amherst College | College/University | Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member | |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amicus Therapeutics UK Ltd.
Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution. | Miscellaneous Commercial Services | Director/Board Member | |
Amicus Therapeutics GmbH
Amicus Therapeutics GmbH BiotechnologyHealth Technology Part of Amicus Therapeutics, Inc., Amicus Therapeutics GmbH is a German biotechnology company that develops therapies for rare and orphan diseases. The company is based in Munich, Germany. The CEOs are Lori Elizabeth Mochan, Christian Ruppenthal, Anita Jane Clifford. The company was founded in 2002. | Biotechnology | Chief Executive Officer | |
Amicus Therapeutics International Holding Ltd.
Amicus Therapeutics International Holding Ltd. Financial ConglomeratesFinance Founded in 2016, Amicus Therapeutics International Holding Ltd. is a British company that functions as an investment holding company. Part of Amicus Therapeutics, Inc., the company is based in Marlow, UK. | Financial Conglomerates | Director/Board Member |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 3 |
Irland | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Finance | 2 |
Operativ
Director/Board Member | 8 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Paula Cobb | 8 |
Lori Elizabeth Mochan | 6 |
- Börse
- Insiders
- Helen Elizabeth Hanby
- Unternehmensverbindungen